Dexcom announces its first-ever over-the-counter CGM Stelo has been cleared by the FDA

CNBC March 5, 2024
Ashley Capoot

Key Points

– Dexcom on Tuesday announced that its new over-the-counter continuous glucose monitor called Stelo has been cleared for use by the FDA, according to a release.

– The new CGM is designed for patients with Type 2 diabetes that do not use insulin, and it is the first glucose biosensor that does not require a prescription.

– Stelo will be available for purchase in the summer of 2024, the release said.

Dexcom on Tuesday announced that its new over-the-counter continuous glucose monitor called Stelo has been cleared for use by the U.S. Food and Drug Administration, and it will be available for purchase online this summer.

Continuous glucose monitors, or CGMs, are small sensors that poke through the...

Today's Sponsors

Today's Sponsor